Literature DB >> 14623198

Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges.

R Masterton1, G Drusano, D L Paterson, G Park.   

Abstract

Resistance to antimicrobial agents is emerging in a wide variety of pathogens, particularly those that cause nosocomial infections. As a consequence of this increasing resistance, morbidity and mortality in nosocomial infections is also increasing. It is therefore critical to treat nosocomial infections appropriately by starting antimicrobial treatment early in the course of infection, using the correct agent, at the most appropriate dose, and for an adequate duration. Indeed, early 'appropriate' antibiotic prescribing has been shown significantly to reduce mortality, length of intensive care unit and hospital stay and overall costs. Early use of the correct antibiotic at the appropriate dose and for an adequate duration are key to initial appropriate antibiotic prescribing. Choosing the right antibiotic depends mainly on the likely pathogen(s) and the expected local susceptibility patterns. Selection of appropriate antimicrobial therapy requires a thorough understanding of the likely microbial cause of the infection, including local susceptibility patterns, as well as the properties of the antimicrobials available for treating these infections, namely spectrum of activity and potency (including activity versus known resistance mechanisms), pharmacokinetic profile and tolerability and safety. This review, based on a series of presentations at the 5th International Conference of the Hospital Infection Society (Edinburgh, 2002) examines the importance of appropriate antimicrobial therapy in nosocomial infections, and provides guidance on how to achieve this.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623198     DOI: 10.1016/s0195-6701(03)00294-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  13 in total

1.  Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  Vanthida Huang; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Mixed Infections of the Paronychium with Prevotella bivia.

Authors:  Ather Mirza; Joseph J Bove; Joshua Litwa; Graham Appelbe
Journal:  J Hand Microsurg       Date:  2011-11-24

Review 3.  Methodology in improving antibiotic implementation policies.

Authors:  Onur Özgenç
Journal:  World J Methodol       Date:  2016-06-26

4.  A prospective study of the case-notes of MRSA-positive patients: a vehicle of MRSA spread.

Authors:  N Hamza; G Bazoua; Y Al-Shajerie; E Kubiak; P James; C Wong
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

5.  Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Authors:  Teena Chopra; Dror Marchaim; Jennifer Veltman; Paul Johnson; Jing J Zhao; Ryan Tansek; Dania Hatahet; Khawar Chaudhry; Jason M Pogue; Hiro Rahbar; Ting-Yi Chen; Thientu Truong; Victor Rodriguez; Joseph Ellsworth; Luigino Bernabela; Ashish Bhargava; Adnan Yousuf; George Alangaden; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

6.  Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.

Authors:  Ferdinand Anton Weinelt; Miriam Songa Stegemann; Anja Theloe; Frieder Pfäfflin; Stephan Achterberg; Franz Weber; Lucas Dübel; Agata Mikolajewska; Alexander Uhrig; Peggy Kiessling; Wilhelm Huisinga; Robin Michelet; Stefanie Hennig; Charlotte Kloft
Journal:  Antibiotics (Basel)       Date:  2022-06-02

7.  Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.

Authors:  M A Pfaller; L B Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

8.  Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000-2008: a retrospective observational study.

Authors:  Yin-Yin Chen; Liang-Yu Chen; Seng-Yi Lin; Pesus Chou; Shu-Yuan Liao; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2012-09-10       Impact factor: 3.090

9.  Changes in gram negative microorganisms' resistance pattern during 4 years period in a referral teaching hospital; a surveillance study.

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Mohammad-Reza Shahidi; Alireza Abdollahi; Sirous Jafari; Zahra Jahangard-Rafsanjani; Azita-Hajhosssein Talasaz
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

10.  Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.

Authors:  Ahlem Trifi; Sami Abdellatif; Cyrine Abdennebi; Foued Daly; Rochdi Nasri; Yosr Touil; Salah Ben Lakhal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-11-16       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.